This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Autosomal Dominant Hypophosphatemic Rickets
Information about Autosomal Dominant Hypophosphatemic Rickets: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Autosomal Dominant Hypophosphatemic Rickets
Most recent studies have shown that Autosomal Dominant Hypophosphatemic Rickets shares some biological mechanisms with autosomal-recessive-hypophosphatemic-vitamin-d-refractory-rickets, bone-pain, calcinosis, congenital-abnormality, dysplasia, familial-hypophosphatemia, familial-hypophosphatemic-bone-disease, fibrous-dysplasia, hypercalciuria, hyperphosphatemia, hypophosphatemia, hypophosphatemic-rickets, kidney-diseases, neoplasms, oncogenic-osteomalacia, osteomalacia, pain, rickets, tumoral-calcinosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Autosomal Dominant Hypophosphatemic Rickets, and have been seen in publications frequently: Aging, Angiogenesis, Bone Development, Bone Mineralization, Cell Proliferation, Excretion, Glomerular Filtration, Glycosylation, Ion Homeostasis, Localization, Mesenchymal To Epithelial Transition, Pathogenesis, Protein Processing, Protein Secretion, Regulation Of Phosphate Transport, Renal Phosphate Excretion, Secretion, Transport
Quite a number of genes have been found to play important roles in Autosomal Dominant Hypophosphatemic Rickets, such as AVPR2, DMP1, DMTF1, FGF23, FGF6, FGF7, FGFR2, GSTP1, KL, MEPE, PHEX, PTH, PTRH1, SFRP4, SLC34A1, SLC34A3, UCN3. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.